Apogee Therapeutics, Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

134.11

+0.02 (0.01%)

Aug 3, 2026, 4:00 PM EDT - Market closed

Apogee Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-305.27	-285.6	-216.87	-93
Net Income	-274.34	-255.84	-182.15	-83.99
Earnings Per Share	-4.33	-4.22	-3.30	-3.36
EPS Growth	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	1,060	730.19	520.65	395.46
Total Debt	8.05	8.85	11.83	2.03
Net Cash (Debt)	1,052	721.34	508.82	393.43
Net Cash Growth	109.73%	41.77%	29.33%	-
Net Cash Per Share	16.55	11.89	9.22	15.73

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-234.54	-227.45	-171.17	-74.76
Capital Expenditures	-0.83	-5.15	-1.15	-0.17
Free Cash Flow	-235.37	-232.6	-172.33	-74.93
Free Cash Flow Growth	-	-	-	-

Valuation

Selected indicators aren't available for this stock.